- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Potential of Targeting ß-Arrestin
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-06
DOI
10.3389/fphar.2019.00124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Arrestin-2–Dependent Signaling Promotes CCR4–mediated Chemotaxis of Murine T-Helper Type 2 Cells
- (2018) Rui Lin et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo
- (2018) Zhenzhen Kong et al. CANCER SCIENCE
- Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma
- (2018) Wen-Ting Peng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model
- (2018) Michael J. Fossler et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention
- (2018) Kristan H. Cleveland et al. MOLECULAR CARCINOGENESIS
- Catalytic activation of β-arrestin by GPCRs
- (2018) Kelsie Eichel et al. NATURE
- Arrestins as rheostats of GPCR signalling
- (2018) J. Silvio Gutkind et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- β‑arrestin2 promotes 5‑FU‑induced apoptosis via the NF‑κB pathway in colorectal cancer
- (2018) Weixia Ren et al. ONCOLOGY REPORTS
- β-Arrestin1 mediates hMENA expression and ovarian cancer metastasis
- (2018) Hamsa Thayele Purayil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of Arrestin-Dependent Signal Transduction
- (2018) Qiuyan Chen et al. TRENDS IN BIOCHEMICAL SCIENCES
- Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
- (2018) David L. Gray et al. Nature Communications
- Lack of beta-arrestin signaling in the absence of active G proteins
- (2018) Manuel Grundmann et al. Nature Communications
- Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer
- (2018) Victoria El-Khoury et al. BRITISH JOURNAL OF CANCER
- Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)
- (2017) Peter S. Pang et al. EUROPEAN HEART JOURNAL
- The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review)
- (2017) Qing Song et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- β-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/β-catenin signaling in mice
- (2017) Huiyan Xu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents
- (2017) Ahmad A Altarifi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
- (2017) Yuri K. Peterson et al. PHARMACOLOGICAL REVIEWS
- β2-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility
- (2017) Long P. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype
- (2017) Radhika Joshi et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK
- (2017) Morgan O’Hayre et al. Science Signaling
- Gαi is required for carvedilol-induced β1 adrenergic receptor β-arrestin biased signaling
- (2017) Jialu Wang et al. Nature Communications
- Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung Cancer
- (2017) Lei Cong et al. Journal of Cancer
- Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK
- (2017) Morgan O’Hayre et al. Science Signaling
- Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
- (2017) Marco Solmi et al. Therapeutics and Clinical Risk Management
- A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
- (2017) Neil Singla et al. Journal of Pain Research
- Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy
- (2017) Larissa B. Teixeira et al. Scientific Reports
- Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase–Knockout Mice
- (2016) Gloria S. Forkuo et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Quantification of adenosine A 1 receptor biased agonism: Implications for drug discovery
- (2016) Jo-Anne Baltos et al. BIOCHEMICAL PHARMACOLOGY
- From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins
- (2016) Richard Carr et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation
- (2016) Dean P. Staus et al. NATURE
- β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation
- (2016) K. Eichel et al. NATURE CELL BIOLOGY
- A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
- (2016) Eugene R. Viscusi et al. PAIN
- β-arrestin–biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction
- (2016) Richard Carr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct cortical and striatal actions of a β-arrestin–biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties
- (2016) Nikhil M. Urs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
- (2016) T. G. Murali Dhar et al. ACS Medicinal Chemistry Letters
- The emerging roles of β-arrestins in fibrotic diseases
- (2015) Yuan-jing Gu et al. ACTA PHARMACOLOGICA SINICA
- Genetic Deletion of β-Arrestin-2 and the Mitigation of Established Airway Hyperresponsiveness in a Murine Asthma Model
- (2015) Minyong Chen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Multifaceted role of β-arrestins in inflammation and disease
- (2015) D Sharma et al. GENES AND IMMUNITY
- Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice
- (2015) Su M Park et al. NEUROPSYCHOPHARMACOLOGY
- Targeting β-arrestin2 in the treatment of l-DOPA–induced dyskinesia in Parkinson’s disease
- (2015) Nikhil M. Urs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Physiological implications of biased signaling at histamine H2 receptors
- (2015) Natalia Alonso et al. Frontiers in Pharmacology
- Development and Characterization of Pepducins as Gs-biased Allosteric Agonists
- (2014) Richard Carr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium
- (2013) Michelle M. Monasky et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Ligands Raise the Constraint That Limits Constitutive Activation in G Protein-coupled Opioid Receptors
- (2013) Vanessa Vezzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor
- (2013) Jeremy Shonberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease
- (2013) Teng Jiang et al. MOLECULAR NEUROBIOLOGY
- Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
- (2013) J. Quoyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New advances in beta-blocker therapy in heart failure
- (2013) Vincenzo Barrese et al. Frontiers in Physiology
- β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury
- (2012) Ki-Seok Kim et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- β2-Adrenoceptor Agonists Are Required for Development of the Asthma Phenotype in a Murine Model
- (2012) Vaidehi J. Thanawala et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- β-Arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology
- (2012) Xiaosong Liu et al. CELL RESEARCH
- TRV120027, a Novel β-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure
- (2012) Guido Boerrigter et al. Circulation-Heart Failure
- β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease
- (2012) Amantha Thathiah et al. NATURE MEDICINE
- Impedance Responses Reveal β2-Adrenergic Receptor Signaling Pluridimensionality and Allow Classification of Ligands with Distinct Signaling Profiles
- (2012) Wayne Stallaert et al. PLoS One
- Cofilin under control of -arrestin-2 in NMDA-dependent dendritic spine plasticity, long-term depression (LTD), and learning
- (2012) C. G. Pontrello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -Arrestin2 mediates the initiation and progression of myeloid leukemia
- (2012) M. Fereshteh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines
- (2011) Guido Boerrigter et al. Circulation-Heart Failure
- Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
- (2011) T. R. Cox et al. Disease Models & Mechanisms
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- Structure of a nanobody-stabilized active state of the β2 adrenoceptor
- (2011) Søren G. F. Rasmussen et al. NATURE
- -Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix
- (2011) A. K. Lovgren et al. Science Translational Medicine
- β-arrestin-mediated receptor trafficking and signal transduction
- (2011) Sudha K. Shenoy et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Meningococcus Hijacks a β2-Adrenoceptor/β-Arrestin Pathway to Cross Brain Microvasculature Endothelium
- (2010) Mathieu Coureuil et al. CELL
- β-Adrenoceptor inverse agonists in asthma
- (2010) Burton F Dickey et al. CURRENT OPINION IN PHARMACOLOGY
- Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions
- (2010) Paola Molinari et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- β-Arrestin: A signaling molecule and potential therapeutic target for heart failure
- (2010) Nabila Noor et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
- (2010) B. Tchernychev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 27-kDa Heat Shock Protein Confers Cytoprotective Effects through a 2-Adrenergic Receptor Agonist-Initiated Complex with -Arrestin
- (2009) L. Rojanathammanee et al. MOLECULAR PHARMACOLOGY
- An essential function for β-arrestin 2 in the inhibitory signaling of natural killer cells
- (2008) Ming-Can Yu et al. NATURE IMMUNOLOGY
- Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and β-arrestin-1 in monocytoid cells
- (2007) Shigeki Tsutsui et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started